acquired
Stage
About
Ouro Medicines is a San Francisco–based biotechnology company developing immune-reset therapeutics for people with chronic autoimmune and immune-mediated diseases. The company is advancing clinical-stage programs (e.g., OM336) to modulate and restore immune balance.
Explore Ouro Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.